Typically, Ozempic is considered for weight loss in patients with a BMI of 27 or higher, particularly if they have additional weight-related health conditions, or a BMI of 30 or higher regardless of other health issues
State-of-the-art research and development facilities, favorable government policies, and the presence of key players drive the market
Growth and pubertal development in children and adolescents: effects of diet and physical activity
Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines
While topical application results in lower systemic absorption than injection, some of the peptide can still enter the bloodstream
Still, the clear pattern seen with Wegovy and the higher risk in males suggests that doctors should monitor patients carefully, especially those receiving the higher doses for obesity